These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 307956)

  • 1. Macrophage requirement for growth of a murine fibrosarcoma.
    Evans R
    Br J Cancer; 1978 Jun; 37(6):1086-9. PubMed ID: 307956
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo suppression of syngeneic murine fibrosarcoma by macrophages and lymphocytes.
    Gupta N; Aikat BK; Sehgal S
    Indian J Med Res; 1982 Apr; 75():583-9. PubMed ID: 7106899
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of cytomegalovirus infection on the growth of murine fibrosarcomas--evidence for two separate host defense mechanisms against tumors.
    Lannin DR; Howard RJ; Yu S; Collins AL; McKhann CF
    Surg Forum; 1979; 30():145-7. PubMed ID: 231846
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity to transplantable carcinogen induced fibrosarcomas in B2/B2 chickens. II. Macrophage dependency of adoptive T cell mediated tumor immunity.
    Palladino MA; Thorbecke GJ
    Cell Immunol; 1978 Jul; 38(2):350-64. PubMed ID: 307987
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage content of tumours in relation to metastatic spread and host immune reaction.
    Eccles SA; Alexander P
    Nature; 1974 Aug; 250(5468):667-9. PubMed ID: 4546859
    [No Abstract]   [Full Text] [Related]  

  • 6. Recruitment of effector T lymphocytes against a tumor allograft by T lymphocytes sensitized in vitro.
    Treves AJ; Cohen IR
    J Natl Cancer Inst; 1973 Dec; 51(6):1919-25. PubMed ID: 4543604
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.
    Elgert KD; Connolly KM
    Oncology; 1980; 37(2):101-6. PubMed ID: 6444706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses.
    Garrigues HJ; Romero P; Hellström I; Hellström KE
    Cell Immunol; 1981 May; 60(1):109-18. PubMed ID: 6453654
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of PSK on the recovery of macrophage function and T cell-mediated immunity in tumor-bearing mice].
    Tsuru S; Taniguchi M; Zinnaka Y; Nomoto K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2375-80. PubMed ID: 6333849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow stem cell response to tumour grafts.
    Croizat H; Frindel E
    Rev Eur Etud Clin Biol; 1972 Feb; 17(2):200-4. PubMed ID: 5066340
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of mitogen and immune blastogenesis by two distinct populations of supressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression.
    Farrar WL; Elgert KD
    Int J Cancer; 1978 Aug; 22(2):142-51. PubMed ID: 308934
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility of malignant and normal target cells to the cytotoxic action of bone-marrow macrophages activated in vitro with the macrophage cytotoxicity factor (MCF).
    Lohmann-Matthes ML; Kolb B; Meerpohl HG
    Cell Immunol; 1978 Dec; 41(2):231-9. PubMed ID: 729007
    [No Abstract]   [Full Text] [Related]  

  • 13. Homing of macrophages in tumor immunity.
    Gupta N; Aikat BK; Sehgal S
    Indian J Med Res; 1982 Sep; 76():424-9. PubMed ID: 7174033
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific triggering of macrophage accumulation at the site of secondary tumor challenge in mice with concomitant tumor immunity.
    Hopper KE; Nelson DS
    Cell Immunol; 1979 Sep; 47(1):163-9. PubMed ID: 509531
    [No Abstract]   [Full Text] [Related]  

  • 15. Level of macrophage induction during tumor growth: primed or activated?
    Burger CJ; Elgert KD
    Immunol Commun; 1983; 12(3):285-90. PubMed ID: 6885106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A; Tandon P; Sarna S
    Arch Geschwulstforsch; 1985; 55(1):47-61. PubMed ID: 3872651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals.
    Gorczynski RM
    J Immunol; 1974 Feb; 112(2):533-9. PubMed ID: 4360545
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.
    North RJ; Kirstein DP
    J Exp Med; 1977 Feb; 145(2):275-92. PubMed ID: 401860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymus-dependent response: too little and too late for immunosurveillance.
    Lannin DR; Yu S; McKhann CF
    Transplantation; 1982 Jan; 33(1):99-100. PubMed ID: 6977902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.